- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/52 - Proteinases derived from bacteria
Patent holdings for IPC class C12N 9/52
Total number of patents in this class: 1124
10-year publication summary
90
|
87
|
86
|
94
|
85
|
81
|
84
|
87
|
97
|
58
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Novozymes A/S | 3320 |
76 |
President and Fellows of Harvard College | 5976 |
44 |
Allergan, Inc. | 2346 |
33 |
Ipsen Biopharm Limited | 262 |
23 |
The Broad Institute, Inc. | 1818 |
19 |
The Regents of the University of California | 19929 |
17 |
Massachusetts Institute of Technology | 10055 |
16 |
Amano Enzyme Inc. | 391 |
14 |
Children's Medical Center Corporation | 1864 |
14 |
Ipsen Bioinnovation Limited | 40 |
14 |
University of Washington | 2330 |
14 |
Hoffmann-La Roche Inc. | 3422 |
13 |
MERZ PHARMA GmbH & CO. KGaA | 613 |
13 |
Danisco US Inc. | 1102 |
12 |
Endo Biologics Limited | 30 |
12 |
Henkel AG & Co. KGaA | 10574 |
11 |
Biomadison, Inc. | 50 |
11 |
HANSA Biopharma AB | 65 |
11 |
ContraFect Corporation | 72 |
11 |
Board of Trustees of the University of Arkansas | 810 |
10 |
Other owners | 736 |